{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:06:02Z","timestamp":1781831162683,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jpba.2024.116401","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:25:59Z","timestamp":1722965159000},"page":"116401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of a UHPLC-MS\/MS method for the quantification of Pristinamycin \u2160A and \u2161A in beagle dog plasma and its pharmacokinetic application"],"prefix":"10.1016","volume":"251","author":[{"given":"Tao","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengting","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaikai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqiang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lushan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jpba.2024.116401_bib1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14787210.2021.1834851","article-title":"Streptogramins for the treatment of infections caused by Gram-positive pathogens","volume":"19","author":"Reissier","year":"2021","journal-title":"Expert Rev. Anti. Infect. Ther."},{"issue":"9","key":"10.1016\/j.jpba.2024.116401_bib2","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/jac\/dku167","article-title":"Pristinamycin: old drug, new tricks?","volume":"69","author":"Cooper","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.jpba.2024.116401_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijmm.2013.08.008","article-title":"Streptogramins - two are better than one!","volume":"304","author":"Mast","year":"2014","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.jpba.2024.116401_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1741-7007-2-4","article-title":"Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin","volume":"2","author":"Harms","year":"2004","journal-title":"BMC Biol."},{"key":"10.1016\/j.jpba.2024.116401_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/39.suppl_1.7","article-title":"Inhibition of protein synthesis by streptogramins and related antibiotics","volume":"39","author":"Cocito","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2024.116401_bib6","article-title":"Analysis of the application of high performance liquid chromatography","volume":"769","author":"Chen","year":"2021","journal-title":"IOP Conf. Ser.: Earth Environ. Sci."},{"issue":"1) (","key":"10.1016\/j.jpba.2024.116401_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0378-4347(88)80022-7","article-title":"Determination of PIA and PIIA, the two main components of pristinamycin, by high-performance liquid chromatography in plasma","volume":"425","author":"Koechlin","year":"1988","journal-title":"J. Chromatogr."},{"issue":"1","key":"10.1016\/j.jpba.2024.116401_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/03639045.2023.2182602","article-title":"Preparation and evaluation in vitro and in vivo of pristinamycin enteric-coated granules based on albumin nanoparticles","volume":"49","author":"Shan","year":"2023","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"4","key":"10.1016\/j.jpba.2024.116401_bib9","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1039\/C9AN02145K","article-title":"Current developments in LC-MS for pharmaceutical analysis","volume":"145","author":"Beccaria","year":"2020","journal-title":"Analyst"},{"issue":"5","key":"10.1016\/j.jpba.2024.116401_bib10","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.3390\/molecules28052127","article-title":"LC-MS\/MS application in pharmacotoxicological field: current state and new applications","volume":"28","author":"D'Ovidio","year":"2023","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jpba.2024.116401_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5347","article-title":"Cutting-edge LC-MS\/MS applications in clinical mass spectrometry: focusing on analysis of drugs and metabolites","volume":"36","author":"Maekawa","year":"2022","journal-title":"Biomed. Chromatogr."},{"issue":"6","key":"10.1016\/j.jpba.2024.116401_bib12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0731-7085(03)00231-0","article-title":"LC-MS\/MS determination of synercid injections","volume":"32","author":"Abdel-Hamid","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116401_bib13","unstructured":"Draft Guidance for Industry on Bioanalytical Method Validation, in: FDA (Ed.) 2018."},{"issue":"11","key":"10.1016\/j.jpba.2024.116401_bib14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0399-077X(05)80406-8","article-title":"Etude de la pharmacocin\u00e9tique des pristinamycines chez des volontaires en bonne sant\u00e9","volume":"25","author":"Chevalier","year":"1995","journal-title":"Med. Mal. Infect."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T06:15:37Z","timestamp":1742192137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524004412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":14,"alternative-id":["S0731708524004412"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116401","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a UHPLC-MS\/MS method for the quantification of Pristinamycin \u2160A and \u2161A in beagle dog plasma and its pharmacokinetic application","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116401"}}